ALMS Alumis Inc.
Alumis Inc. (ALMS) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $507.0K.
Where they traded
Last open-market purchase: September 8, 2026 , by AKKARAJU SRINIVAS .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Schroer John R. | Chief Financial Officer | Sell | 794 | $6.52 | $5.2K | 23,924 −3.2% of holding | |
| Hardiman Roy C. | Chief Business & Strategy Ofcr | Sell | 652 | $6.52 | $4.3K | 207,094 −0.3% of holding | |
| Goldstein David M | Chief Scientific Officer | Sell | 629 | $6.52 | $4.1K | 30,341 −2% of holding | |
| Bradley Mark Christopher | Chief Development Officer | Sell | 623 | $6.52 | $4.1K | 47,910 −1.3% of holding | |
| Drappa Jorn | Chief Medical Officer | Sell | 593 | $6.52 | $3.9K | 56,299 −1% of holding | |
| Pangali Sanam | Chief Legal Officer | Sell | 332 | $6.52 | $2.2K | 9,415 −3.4% of holding | |
| AKKARAJU SRINIVAS 2 fills | Director | Buy | 546,581 | $10.63 | $5.8M | 4,937,026 | |
| AKKARAJU SRINIVAS 2 fills | Director | Sell | 96,131 | $10.55 | $1.0M | 4,663,735 −2% of holding | |
| AKKARAJU SRINIVAS 2 fills | Director | Buy | 440,140 | $11.17 | $4.9M | 4,711,801 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.